Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Transforming Behavioral Healthcare to Improve the Quality of Life for Individuals With Childhood-onset Lupus
Michigan State University
175 participants
Sep 12, 2024
INTERVENTIONAL
Conditions
Summary
This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.
Eligibility
Inclusion Criteria5
- \) be diagnosed with cSLE, meeting the revised American College of Rheumatology Classification Criteria for SLE by age 18 years
- \) be between the ages of 12 and 22 years
- \) in recognition of the heterogeneity of cSLE symptoms, have elevations in fatigue (i.e., T scores ≥60; or at least moderate symptoms, on the PROMIS measure) OR depressive symptoms (≥5 on the PHQ-9, T Score ≥ 60 on the BDI or CDI II ), OR pain (i.e., average pain ≥3 out of 10 on the Pain VAS)
- \) have English language proficiency (their primary caregiver can have English or Spanish language proficiency for the child to enroll)
- \) those under age 18 years (US), or 16 years (Canada) must have a consenting caregiver
Exclusion Criteria3
- \) other chronic medical conditions (e.g., juvenile arthritis)
- \) a documented developmental delay, severe cognitive impairment, or thought disorder
- \) an untreated major psychiatric illness (e.g., bipolar disorder, psychosis, severe depression (PHQ9 score ≥21, BDI/CDI II \> 90) or active suicidal ideation (SI), based on the Pediatric Health Questionnaire (PHQ-9) items plus clinical interview; see Measures section)
Interventions
TEACH is a cognitive behavioral coping skills program. It consists of six one-hour weekly sessions that are conducted either in-person or remotely.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06232304